Training general practitioners in early identification and anticipatory palliative care planning: a randomized controlled trial by Bregje Thoonsen et al.
RESEARCH ARTICLE Open Access
Training general practitioners in early
identification and anticipatory palliative
care planning: a randomized controlled trial
Bregje Thoonsen1, Kris Vissers1, S. Verhagen1, J. Prins2, H. Bor3, C. van Weel3,4, M. Groot1 and Y. Engels1*
Abstract
Background: Most patients with advanced cancer, debilitating COPD or chronic heart failure (CHF) live at home.
General practitioners (GPs) asked for guidance in how to recognize patients in need of palliative care in a timely
way and to structure anticipatory care. For that reason, we developed a training for GPs in identifying patients in
need of palliative care and in structuring anticipatory palliative care planning and studied its effect on out-of-hours
contacts, contacts with their own GP, hospitalizations and place of death.
Methods: We performed a cluster randomised controlled trial. GPs in the intervention group were trained in
identifying patients in need of palliative care and anticipatory care planning. Next, for each identified patient, they
were offered a coaching session with a specialist in palliative care to fine-tune a structured care plan. The GPs in
the control group did not receive training or coaching, and were asked to provide care as usual.
After one year, characteristics of patients deceased of cancer, COPD or CHF in both study groups were compared
with mixed effects models for out-of-hours contacts (primary outcome), contacts with their own GP, place of death
and hospitalizations in the last months of their life (secondary outcomes). As a post-hoc analysis, of identified
patients (of the intervention GPs) these figures were compared to all other deceased patients, who had not been
identified as in need of palliative care.
Results: We did not find any differences between the intervention and control group. Yet, only half of the trained
GPs (28) identified patients (52), which was only 24 % of the deceased patients. Those identified patients had
significantly more contacts with their own GP (B 4.5218; p <0.0006), were less often hospitalized (OR 0.485; p
0.0437) more often died at home (OR 2.126; p 0.0572) and less often died in the hospital (OR 0.380; p 0.0449).
Conclusions: Although we did not find differences between the intervention and control group, we found in a
post-hoc analysis that those patients that had been identified as in need of palliative care had more contacts with
their GP, less hospitalizations, and more often died at home. We recommend future controlled studies that try to
further increase identification of patients eligible for anticipatory palliative care.
The Netherlands National Trial Register: NTR2815 date 07-04-2010
Background
In developed countries cancer, cardiovascular diseases
and respiratory diseases are the main causes of death
[1, 2]. Each year, in the Netherlands, about 140,000
persons die and two third of them die non-acutely of
one of these three diseases (http://statline.cbs.nl/Stat
Web/publication/?VW=T&DM=SLNL&PA=71594ned).
Particularly in advanced stages of these diseases,
symptom burden is high [3–5].
In order to improve the care for patients with incur-
able, life-limiting diseases, the WHO stated in 2002 that
palliative care should be initiated in an early phase of
the disease. A timely start facilitates anticipatory care
planning in order to meet patient wishes and needs, to
relieve symptoms and to prevent future symptoms and
problems. Regardless of the WHO recommendation, pal-
liative care is often restricted to a reactive approach and
to the relief of physical symptoms in the terminal phase,
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often resulting in emergency visits by the general practi-
tioner (GP) [6], unplanned transfers [7, 8] and hospital
admissions [9, 10]. Consequently, too many patients die
in another place than preferred, often with ineffective,
costly and unwanted interventions [11–13].
Anticipatory care planning by earlier identification of
the needs of patients in an advanced stage of their dis-
ease appeared to improve the quality of their remaining
life, to decrease the number of aggressive futile interven-
tions and depressed mood and even to prolong life in
patients with advanced cancer [14–16].
Identification of patients who can benefit from antici-
patory palliative care alongside or instead of disease-
oriented therapies, is challenging particularly in patients
with chronic obstructive pulmonary disease (COPD) or
chronic heart failure (CHF), due to the fact that the
course of these disease trajectories is difficult to predict
[17–21]. In addition, these patients often don’t realise
that they have a limited life expectancy [22]. In order to
facilitate the identification of patients at risk of deterior-
ation or dying, and thus for anticipatory palliative care,
several sets of indicators have been developed, such as
the Supportive and Palliative Care Indicators Tool
(SPICT) in Scotland, the Prognostic Indicator Guide
(PIG) in England, Neccesidades palliativas (NECPAL) in
Spain and the Radboud indicators for Palliative Care
needs (RADPAC) in the Netherlands [23]. These tools
contain general or disease-specific indicators of decline.
Examples of these indicators are repeated hospital ad-
missions, weight loss, decrease in functional status, and
the surprise question (Would you be surprised if this pa-
tient were to die in the next twelve months?).
In the Netherlands patients are registered with a doc-
tor’s general practice, as part of their health care insur-
ance. This structures a relation with a personal GP, who
provides care for the large majority of their health prob-
lems presented and is the gatekeeper to specialist and
hospital care. Through this structure, GPs have an over-
view and often intimate knowledge of the patient and
his/her health conditions and social environment. This
primary care-based structure plays an important role in
coordinating early palliative care. GPs consider palliative
care an attractive and essential part of their task, but ex-
perience difficulties with timely initiation and their co-
ordinating role in palliative care [24, 25].
For those reasons, we developed a training for GPs in
using a previously developed set of identification indica-
tors, the RADPAC [26], in planning and providing struc-
tured anticipatory palliative care and in communicating
end-of-life issues with the patient. We expected that this
training would improve the care for palliative patients
with cancer, COPD or CHF in the form of less contacts
with the out-of-hours hours primary care cooperative, a
decreased number of hospitalizations in the last three
months of life, an increased number of contacts with
their own GP in the last month of life and an increased
number of patients that would die at home. We tested
this in a cluster randomised controlled trial (RCT).
Methods
Design
A clustered, two-armed RCT was performed, with the
GP as cluster. The study ran from February 2009 until
February 2011.
Ethical considerations
The study was approved by the research ethics commit-
tee of the Radboud University Nijmegen Medical Center
in accordance with the Medical Research Involving Hu-
man Subjects Acts (WMO). It also conforms to the
Helsinki Declaration.
Participants
All GP practices in two regions of the comprehensive
cancer centre of the Netherlands were invited by mail to
participate. GPs were excluded if they were a consultant
in a palliative care team. Participating GPs were strati-
fied for working hours (part-time or full-time) and for
degree of urbanization of their general practice (urban
or rural) and they were randomly assigned to the inter-
vention or control group by an independent statistician.
To prevent contamination, GPs working together in the
same practice were allocated to the same study group.
Borland C software was used to randomly allocate GPs,
as sequentially numbered containers, to the strata of one
of both groups.
Intervention
The intervention, described in detail elsewhere [27],
consisted of three consecutive parts: 1. a five hour group
training in early identification of those patients in their
practice that can be considered as being palliative pa-
tients, by means of the RADPAC [26], and in proactive
care planning, 2. an individual coaching session by phone
with a physician specialized in palliative care, per identi-
fied palliative patient for the GP and 3. two additional peer
group sessions with the GPs in the intervention group a
few months after start of the intervention, with a focus on
patient – GP communication regarding the initiation of a
palliative care trajectory. The GPs in the intervention
group were invited to use the RADPAC indicators to
screen the medical records of all persons in their practice
to identify those patients with CHF, COPD or cancer who
potentially could benefit from a palliative care approach.
They were also asked to use this screening instrument
whenever new data of any patient with one of these three
diseases became available, in order to timely identify the
change from a curative to a palliative trajectory. They were
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asked to consider and start structured anticipatory pallia-
tive care for every identified patient. The GPs discussed
palliative care and the study with the patient, and provided
him or her a brochure with information about palliative
care, the content of the study and what participation
would imply for the patient.
GPs in the control group were asked to provide care
as usual. Although this usual care differs per GP, they all
have easy access to a large number of palliative care
standards (www.Oncoline.nl), and each physician and
nurse in the Netherlands can consult a specialist in pal-
liative care 24/7 by phone [28].
Data collection
At baseline, demographics and practice characteristics of
each participating GP were collected, as well as their
interest in palliative care (on a numeric rating scale
(NRS) from 0, not interested at all to 10, extremely in-
terested) and their confidence in providing palliative care
by themselves (NRS from 0, not confident at all to 10,
extremely confident).
If the patient was interested to participate, the GP
asked him or her to sign an informed consent form,
which was faxed to the researcher, together with a ques-
tionnaire with characteristics of the patient. The con-
sulted palliative care specialists were asked to register
each coaching session that they had with the GPs.
After 12 months, GPs that had not yet identified any
patients for proactive palliative care were phoned by the
research assistant and were asked in the form of an open
question what the reason for non-inclusion was.
One year after start of the study, a questionnaire was
sent to each GP in as well the intervention as the control
group. They were asked to provide anonymous data, col-
lected from the medical records of all patients that died in
the past 12 months. This data included whether or not the
patient died a sudden death, cause of death, age, gender,
number and type of contacts with the GP out-of-hours
service (by phone, consultation at the service, home visit)
in the last three months before death, number and type of
contacts with their own GP in the last month before death
(phone calls and home visits during office hours and
phone calls and home visits during out of office hours),
place of death and number of hospital admissions in the
last three months of life. Regarding out-of-hours contacts
and contact with their own GP we chose a limited period
of respectively one and three months before death, as we
considered this a feasible period to check the electronic
medical record, and as such contacts are most frequent
near the end of life.
Statistical analyses
The primary outcome measure was the number of con-
tacts with the out-of-hours GP cooperative. We estimated
that with 96 patients in each group, the study would have
an 80 % power to detect a significance between the inter-
vention and control group, which would be a 20 % reduc-
tion of out-of-hours contacts [27].
Statistical analysis was performed with the use of SPSS
software, version 20.0 and with SAS software, version
9.2. Descriptive statistics were used to calculate fre-
quencies, means, and standard deviations of the study
variables. Differences between GPs in baseline charac-
teristics were assessed with the use of chi-square tests
for categorical variables and Student’s t-tests for con-
tinuous variables. To study differences, between de-
ceased patients in both study groups, mixed effects
models were used (SAS GLIMMIX), with the GP as a
cluster. In this model, the type of disease the patient died
of, the age of the GP, working hours, interest in palliative
care, and estimation of the GP’s own capacity were in-
cluded in the model as possible confounders.
It appeared that only a portion of the deceased pa-
tients had actually been identified as in need of palliative
care in the intervention group. Therefore we performed
a post-hoc analysis. We also used the same model to
study differences between those patients that had been
identified as in need of palliative care by GPs in the
intervention group, and all other deceased patients (in
as well the control and the intervention group).
Results
Within a period of one month, 159 GPs positively
responded to the invitation to participate (Fig. 1). After
stratification, they were randomly assigned to the inter-
vention (n = 80) or control group (n = 79). For various
reasons, 22 GPs in the intervention group were not able
to join the training course. A majority of these 22 GPs
worked fulltime (60 %), had slightly less years of experi-
ence (20 % had 0–5 years), worked in a group or health
center (50 %), and had a larger patient list (2684 pa-
tients). Yet, the estimated number of palliative patients
in this group was lower (only 23.8 % estimated to have 5
or more palliative patients per year).
Additionally, one GP from the intervention group and
2 GPs from the control group were excluded because
they were already trained in specialised palliative care.
For those reasons, 57 GPs received the RADPAC indica-
tors and the training and 77 GPs were considered as
control group (Fig. 1).
Of the 57 GPs that received the initial training, 28 GPs
also followed the two additional peer group sessions.
The characteristics of trained GPs in the intervention
and GPs in the control arm did not differ in mean age,
gender, working hours, years of experience and use of a
consultation service for palliative care. Also their interest
in palliative care and the estimation of their own cap-
acity to provide palliative care was the same in both
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groups (Table 1). Fewer GPs in the intervention arm
worked in single-handed practices. The degree of urban-
isation of their practice was about the same in both
groups, as well as the size of their patient list.
Of the 57 trained GPs in the intervention group, 28
GPs identified 52 patients (0.91 per GP; 0–4) and in 33
cases the GP had an individual coaching session with
the specialist in palliative care by phone (0.58 per GP).
Twenty-nine GPs in the intervention group did not
identify any suitable patient for proactive palliative care.
Reasons for not having included any patients, as men-
tioned by the GPs during a phone call, were having
had no patients that met the RADPAC indicators, dif-
ficulty initiating an appropriate discussion on pro-
active palliative care, or rapid deterioration or death
immediately after having communicated palliative care
with the patient.
Seventy-seven of the 134 GPs (57 %) returned the
questionnaire with retrospective data of deceased pa-
tients: 38 of the 57 GPs (67 %) in the intervention group
and 39 of the 77 GPs (48 %) in the control group. In
total, data from 622 deceased patients was retrieved, of
which 487 (78 %) died of cancer, COPD or CHF or a
combination of these.
In the intervention (I) and control (C) group compar-
able numbers of patients per GP died of cancer, CHF or
COPD within the past 12 months (I:5.7; C: 6.9). Mean
age of the patients (I: 73; C: 74) was the same as well as
the gender distribution (male patients: I: 53 %; C: 56 %).
The primary diagnosis of the deceased patients was
cancer (I 70 %; C: 66 %), followed by CHF (I: 15 %; C:
19 %), COPD (I: 12 %; C: 7 %) or a combination of these
diseases (I:3 %; C: 8 %) (Table 2).
In the mixed model analyses, we found intra cluster
coefficients (ICCs) from 0.04 (dying at home) to 0.14
(out-of-hours contacts). We found no differences be-
tween the intervention and control group in the number
of contacts with the GP out-of-hours cooperative in that
last three months, nor in the number of contacts a pa-
tient had with their own GP in the last month, hospitali-
sations in the last three months, dying at home or dying
in the hospital (Table 3).
There was a relation found between the cause of death
and the number of contacts that the patient had with their
own GP within the last month of life (p < 0.0001) (Table
3). For patients with cancer, the number of contacts in the
last month of life with their own GP was higher than for
patients with CHF, COPD or a combination of these dis-
eases. Cause of death was also related to having had at
least one hospitalization in the last three months of life (p
0.0132). Patients with COPD were more often hospital-
ized, as well as those patients with a combination of these
diseases, while patients with CHF had smaller odds to be
hospitalized. Finally, the cause of death was related to
dying at home (p < 0.0001), and to dying in the hospital (p
0.0009). Patients with cancer died more often at home
and less often in the hospital than patients with one of the
other causes of death.
Fig. 1 Enrolment, follow up and analyses of GPs
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Post-hoc analysis: identified patients versus all other
patients
Of the 52 patients that had been identified as in need of
palliative care, there were 50 with available data; two pa-
tients had moved and it was not possible to follow up on
their status. One patient (with COPD) was still alive at
the moment that the retrospective data was collected.
Data of the remaining 49 deceased patients was com-
pared to data of all other patients from GPs in the inter-
vention as well as the control group (n = 437) that died
of cancer, COPD or CHF or a combination of these.
Table 4 shows that the identified patients were youn-
ger than the other patients (64.8 versus 74.6 years). Also
their primary diagnosis differed; the identified patients
were more likely to have cancer (86 versus 66 %), and
less often CHF (4 % versus 19 %).
The number of contacts in the last three months of life
with the out-of-hours GP service was the same in both
groups. Yet, the identified patients had more contacts
with their own GP in the last month of life (13.00 versus
7.48). Also the location of death differed: the identified
patients died at home more often (67 versus 45 %) and
less often in the hospital (14 versus 32 %) (Table 4).
Finally, a smaller percentage of the identified patients
had had at least one hospitalisation in the last three
months of their life as compared to the other patients
(42 versus 61). The mean number of hospital admissions
of identified patients was also lower (0.60 versus 0.89).
We found no differences in number of contacts with
the out-of-hours GP cooperative in the clustered model,
controlled for GP clusters, cause of death (cancer, CHF,
COPD or a combination of these), the GP working part-
time or fulltime, age of the GP, interest in palliative care
and self-efficacy regarding providing palliative care
(Table 5). However, there was a difference in the number
of contacts that identified patients had with their own
Table 1 GP and practice characteristics
Intervention Control
(n = 57) (n = 77)
Age mean (sd) 48.54 (7.92) 47.85 (8.16)
Male gender n (%) 36 (63.2) 45 (58.4)
Working hours n (%)
Fulltime 29 (50.9) 41 (53.9)
Parttime 28 (49.1) 35 (46.1)
Years experience n (%)
0–5 6 (10.7) 10 (13.2)
6–10 11 (19.6) 10 (13.2)
≥10 39 (69.6) 56 (73.7)
Interest in pall care1 mean (sd) 8.21 (0.92) 8.09 (1.18)
Estimation of own capacity to provide pall care2 mean (sd) 6.80 (0.92) 6.85 (0.93)
Practice type n (%)
Single-handed 9 (15.8) 19 (24.7)
Dual 28 (49.1) 26 (33.8)
Group or health center 20 (35.1) 32 (41.6)
Urbanisation degree n (%)
High 21 (36.8) 26 (33.8)
Moderate 9 (15.8) 19 (24.7)
Low 18 (31.6) 23 (29.9)
No 9 (15.8) 9 (11.7)
Patient list mean (sd) 1710 (412) 1730 (417)
Estimated number of palliative patients/year n (%)
≤2 4 (7.1) 7 (9.2)
3–5 29 (51.8) 43 (56.6)
5–9 20 (35.7) 23 (30.3)
≥10 3 (5.4) 3 (3.9)
1Interest in palliative care: numeric rating scale (NRS) from 0 (no interest at all) to 10 (extremely interested)
2Estimation of own capability: NRS from 0 (not capable at all) to 10 (extremely capable)
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GP in the last month before death (p 0.0006). They were
less often hospitalized in the last three months of life (p
0.0437), and died less often in the hospital (p 0.0449).
Although they also died more often at home, this differ-
ence was not statistically significant (p 0.0572).
Discussion
This study reports the results of an RCT on the effects
of training GPs in early identification of patients that
could profit from palliative care and in structured antici-
patory palliative care planning. There was no difference
found in the primary outcome: the number of consulta-
tions with the out-of-hours cooperative was the same for
the intervention and control group. Also no effects were
found in the secondary outcome parameters: other types
of contact with their own GP, hospital admissions and
place of death. Yet, in the intervention group only 24 %
of the patients that died of cancer, CHF or COPD, had
been identified as in need of palliative care. In addition,
only half of the trained GPs actually identified patients,
and coaching sessions were requested for only a part of
patients. For those reasons, we performed a post-hoc
analysis in which we studied the outcomes regarding
those patients that had actually been identified by the
trained GPs as in need of palliative care in comparison
to all the other patients from the intervention and con-
trol group. The identified patients had had more contact
with their own GP in the last month of life, had half the
chance to have a hospitalisation in the last three months
of life, had less than half the chance to die in hospital,
and twice the chance of dying at home, although the lat-
ter was not statistically significant. Of the identified pa-
tients 67 % died at home. In a recent study concerning
place of death of home-dwelling patients that died after
Table 2 Patients who died of cancer, COPD or coronary heart failure (CHF) during the intervention period
Intervention Control
(N = 216) (N = 271)
Age in years (mean (sd) 73.0 (14.7) 74.0 (13.1)
Male sex n (%) 106/202 (53 %) 144/258 (56 %)
Primary diagnosis n (%)
Cancer 152/216 (70 %) 178/271 (66 %)
CHF 32/216 (15 %) 52/271 (19 %)
COPD 26/216 (12 %) 20/271 (7 %)
Combination of cancer, COPD, CHF 6/216 (3 %) 21/271 (8 %)
Contact(s) with out-of-hours GP service last 3 months n (%) 114/209 (55 %) 157/268 (59 %)
By phone 0.79 (2.6) 0.80 (1.5)
Consultation at service 0.06 (0.3) 0.09 (0.5)
Home visits 0.85 (1.6) 1.14 (2.2)
Total 1.70 (3.3) 2.03 (2.9)
Contact(s) with own GP last month n (%) 188/212 (89 %) 250/268 (93 %)
By phone office hours 2.33 (2.9) 2.71 (3.0)
Home visits office hours 5.59 (5.1) 4.42 (3.6)
By phone out of office hours 0.19 (0.7) 0.10 (0.5)
Home visits out of office hours 0.46 (1.1) 0.38 (1.1)
Total 8.58 (7.5) 7.62 (6.0)
Location of death n (%)
Home 103/210 (49 %) 124/267 (46 %)
Hospital 67/210 (32 %) 78/267 (29 %)
Nursing home 13/210 (6 %) 16/267 (6 %)
Care home 12/210 (6 %) 21/267 (8 %)
Hospice 14/210 (7 %) 25/267 (9 %)
Other location 1/210 (1 %) 3/267 (1 %)
Hospital admission(s) last 3 months n (%) 116/210 (55 %) 159/255 (62 %)
Hospital admissions last 3 months mean (sd) 0.82 (0.9) 0.89 (0.9)
Data are mean (sd) or n/N (%). Some percentages do not sum to 100 % because of rounding
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Table 3 Mixed effects model estimating the effect of intervention
B1 95 % CI p
Number of contacts with out-of-hours GP service last 3 months
Intervention group 0.4828 −0.733 − 1.698 0.4307
Cause of death2 0.4599
CHF −0.1016 −0.806 – 0.603
COPD −0.4729 −1.403 – 0.457
Combination 0.6775 −0.515 – 1.870
GP works fulltime 1.0229 −0.181 – 2.227 0.0946
Age of GP3 −0.0792 −0.155 − −0.003 0.0418
Interest in palliative care3 −0.8286 −1.461 − −0.196 0.0110
Self-efficacy regarding PC3 0.3191 −0.384 − 1.022 0.3679
Number of contacts with own GP last month
Intervention group 0.7155 −0.935 − 2.366 0.3901
Cause of death2 <.0001
CHF −3.8582 −5.434 − −2.283
COPD −5.0800 −7.173 − −2.987
Combination −4.1761 −6.883 − −1.470
GP works fulltime −1.1778 −2.803 – 0.447 0.1526
Age of GP3 −0.0035 −0.108 – 0.101 0.9474
Interest in palliative care3 0.3770 −0.477 – 1.231 0.3813
Self-efficacy regarding PC3 −0.6855 −1.649 – 0.278 0.1602
Intervention group
OR4 95 % CI p
Hospitalisation(s) last three months yes/no
Intervention group 0.797 0.464 – 1.372 0.4078
Cause of death2 0.0132
CHF 0.729 0.423 – 1.256
COPD 2.300 1.056 – 5.011
Combination 3.165 1.092 – 9.172
GP works fulltime 0.917 0.539 – 1.561 0.7467
Age of GP3 1.017 0.983 – 1.053 0.3207
Interest in palliative care3 0.802 0.606 – 1.061 0.1202
Self-efficacy regarding PC3 1.227 0.895 – 1.682 0.1993
Dying at home yes/no
Intervention group 1.130 0.646 − 1.976 0.6655
Cause of death2 <.0001
CHF 0.393 0.227 – 0.682
COPD 0.174 0.075 – 0.405
Combination 0.167 0.059 – 0.472
GP works fulltime 1.359 0.784 – 2.356 0.2697
Age of GP3 0.995 0.960 – 1.030 0.7644
Interest in palliative care3 1.109 0.833 – 1.477 0.4721
Self-efficacy regarding PC3 0.776 0.558 – 1.079 0.1295
Dying in hospital yes/no
Intervention group 1.095 0.684 – 1.754 0.7012
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Table 3 Mixed effects model estimating the effect of intervention (Continued)
Cause of death2 0.0009
CHF 1.501 0.862 – 2.611
COPD 3.692 1.870 – 7.292
Combination 2.617 1.102 – 6.217
GP works fulltime 0.863 0.541 – 1.376 0.5303
Age of GP3 0.991 0.962 – 1.021 0.5468
Interest in palliative care3 1.021 0.800 – 1.303 0.8654
Self-efficacy regarding PC3 1.254 0.936 – 1.680 0.1271
1) B = difference of means
2) cause of death (cancer, CHF, COPD or combination of those; cancer is reference group), age of GP, working hours, interest in palliative care, and estimation of
own capacity were included in the model as possible confounders
3) Effects of continuous variables are assessed as one unit offsets from the mean
4) OR = odds ratio
Table 4 Difference between those patients that were identified as in need of palliative care and all others
Deceased patients who were identified as in need of
palliative care
Deceased patients without those
identified
(N = 49) (N = 428)
Age mean (sd) 64.8 (12.1) 74.6 (13.7)
Male sex n (%) 30/49 (61 %) 219/409 (54 %)
Primary diagnosis n (%)
Cancer 42/49 (86 %) 287/436 (66 %)
CHF 2/49 (4 %) 82/436 (19 %)
COPD 4/49 (8 %) 41/436 (9 %)
Combination of cancer, COPD, CHF 1/49 (2 %) 26/436 (6 %)
Contact(s) with out-of-hours GP service last
3 months n (%)
24/47 (51 %) 247/430 (57 %)
By phone 1.26 (4.9) 0.74 (1.4)
Consultation at service 0.04 (0.2) 0.08 (0.4)
Home visits 0.64 (1.1) 1.05 (2.1)
Total 1.94 (5.2) 1.88 (2.8)
Contact(s) with own GP last month n (%) 45/49 (92 %) 393/431 (91 %)
By phone office hours means 3.14 (3.8) 2.47 (2.8)
Home visits office hours means 8.27 (6.7) 4.55 (3.8)
By phone out of office hours 0.46 (1.2) 0.11 (0.5)
Home visits out of office hours 1.02 (1.7) 0.35 (1.0)
Total mean 13.00 (9.8) 7.48 (6.0)
Location of death n (%)
Home 33/49 (67 %) 194/428 (45 %)
Hospital 7/49 (14 %) 138/428 (32 %)
Nursing home 5/49 (10 %) 24/428 (6 %)
Care home 0/49 (0 %) 33/428 (8 %)
Hospice 4/49 (8 %) 35/428 (8 %)
Other location 0/49 (0 %) 4/428 (1 %)
Hospital admission(s) last 3 months n (%) 20/48 (42 %) 255/417 (61 %)
Hospital admissions last 3 months mean (sd) 0.60 (1.0) 0.89 (0.9)
Data are mean (sd) or n/N (%). Some percentages do not sum to 100 % because of rounding
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Table 5 Mixed effects model estimating the effect of being identified as in need of palliative care
B1 95 % CI p
Number of contacts with out-of-hours GP cooperative last 3 months
Identified patients −0.0832 −1.156 – 0.989 0.8695
Cause of death2 0.4831
CHF −0.1240 −1.833 – 0.585
COPD −0.470 −1.404 – 0.464
Combination 0.6421 −0.553 – 1.837
GP works fulltime 1.0132 −0.164 – 2.190 0.0904
Age of GP3 −0.0776 −0.152 − −0.003 0.0410
Interest in palliative care3 −0.8049 −1.422 − −0.188 0.0113
Self-efficacy regarding PC3 0.3545 −0.328 – 1.037 0.3033
Number of contacts with own GP last month
Identified patients 4.5218 2.336 – 6.707 0.0006
Cause of death2 <0.0001
CHF −3.5003 −5.054 − −1.947
COPD −4.8675 −6.920 − −2.815
Combination −3.9826 −6.633 − −1.332
GP works fulltime −1.3109 −2.865 – 0.243 0.0970
Age of GP3 −0.0008 −1.101 – 0.099 0.9876
Interest in palliative care3 0.4259 −0.387 – 1.238 0.2993
Self-efficacy regarding PC3 −0.8122 −1.730 – 0.105 0.0817
Intervention group
OR4 95 % CI p
Hospitalisation(s) last three months yes/no
Identified patients 0.485 0.215 – 0.975 0.0437
Cause of death2 0.0117
CHF 0.682 0.395 – 1.179
COPD 2.227 1.017 – 4.879
Combination 3.105 1.074 – 8.973
GP works fulltime 0.939 0.557 – 1.583 0.8094
Age of GP3 1.018 0.984 – 1.054 0.2937
Interest in palliative care3 0.792 0.603 – 1.041 0.0935
Self-efficacy regarding PC3 1.241 0.912 – 1.688 0.1663
Dying at home yes/no
Intervention group 2.126 0.974 – 4.643 0.0572
Cause of death2 <0.0001
CHF 0.418 0.240 – 0.726
COPD 0.177 0.076 – 0.414
Combination 0.172 0.061 – 0.485
GP works fulltime 1.321 0.762 – 2.291 0.3166
Age of GP3 0.995 0.960 – 1.030 0.7629
Interest in palliative care3 1.116 0.839 – 1.483 0.4465
Self-efficacy regarding PC3 0.761 0.549 – 1.055 0.1000
Dying in hospital yes/no
Identified patients 0.380 0.148 – 0.975 0.0449
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a protracted terminal illness, 52.5 % of the Dutch pa-
tients died at home, which is a much lower occurrence
than of our identified patients [29].
The mean age of the identified patients was ten years
younger than that of the other patients. This may have
influenced the place of death, as younger patients are
more likely to have a partner who can take care of them
which may have increased their chance of dying at
home. Also in an English study, the chance of dying at
home or in a hospice was higher for younger patients
[30]. Yet, in a German study, younger patients had a
higher chance to die in hospital [31]. The influence of
age on the outcome is therefore unclear.
The positive effects of the intervention regarding those
patients that had had anticipatory palliative care is in ac-
cordance with several other RCTs. In a Canadian nurse-
led study, early palliative care for patients with advanced
cancer had a significant effect on parameters such as
quality of life and depressed mood [15]. However, they
did not find an effect on the number of hospitalizations.
In an American study, Temel et al. found that early pal-
liative care resulted in an improved quality of life and
mood, less aggressive interventions and prolonged sur-
vival in patients with advanced lung cancer [14]. In a
cluster-RCT in Canada, Zimmermann et al. found a sig-
nificant improvement in quality of life at the end of life
and satisfaction with care, but no significant effect on
the quality of life as measured with the Facit-spiritual
well being of advanced cancer patients 3 months after
inclusion [16]. All three studies were restricted to pa-
tients with cancer, and in all three studies patients were
included via hospitals, in contrast to our study. In these
studies, the intervention was hospital-based and deliv-
ered directly to the patients. In our study GPs were in-
cluded as participants, not patients. We provided them
with training and tools to identify and proactively plan
the care for palliative patients.
Yet, only half of the trained GPs in the intervention
group identified patients in need of palliative care, and
the identified number per GP was only a fraction of the
number of patients that died per GP during this period.
These aspects indicate an identification problem with re-
gard to the RADPAC tool and/or an inclusion threshold.
Secondly, and probably related to the limited number of
identified patients: our intervention addressed GPs,
while it is often a medical specialist who remains the pri-
mary caregiver for patients in their final stage of life.
This is related to the fact that patients still receive
disease-oriented interventions. In such cases, training
GPs without actively involving the medical specialists
will hardly influence the identification of palliative pa-
tients or palliative care planning. Finally, although GPs
are the experts in discussing end-of-life aspects with
their patients, and our intervention further strengthened
this expertise, the reality of daily life still is, that timely
palliative care and involving the patient in anticipating a
care trajectory remains difficult, particularly in non-
cancer patients. Seeing as the entire disease trajectory of
patients with COPD can span 15–20 years, and of pa-
tients with CHF spans 5–10 years, which is much longer
than the trajectory of most patients with cancer, chan-
ging such a long-term relation will require more efforts
than just a training on anticipatory palliative care. Jans-
sen et al. described in 2011 that for several reasons, the
quality of communication about end of life issues with
patients with COPD needs to be improved [22]. Also in
our study, more patients with cancer had been included
than patients with COPD or CHF. This was also one of
the conclusions of a review on palliative patient-GP
communication [32].
Strengths and weaknesses
This is the first RCT to study the effect of training GPs
in identifying patients in need of palliative care and in
providing structured palliative care planning. We were
able to include many GPs in a very short period of time,
which confirms their interest in palliative care [24, 33].
Table 5 Mixed effects model estimating the effect of being identified as in need of palliative care (Continued)
Cause of death2 0.0011
CHF 1.361 0.781 – 2.371
COPD 3.867 1.928 – 7.757
Combination 2.423 1.025 – 5.726
GP works fulltime 0.884 0.554 – 1.409 0.5991
Age of GP3 0.989 0.960 – 1.019 0.4619
Interest in palliative care3 1.031 0.809 – 1.313 0.8025
Self-efficacy regarding PC3 1.309 0.980 – 1.748 0.0678
1) B = difference of means
2) cause of death (cancer, CHF, COPD or combination of those; cancer is reference group), age of GP, working hours, interest in palliative care, and estimation of
own capacity were included in the model as possible confounders
3) Effects of continuous variables are assessed as one unit offsets from the mean
4) OR = odds ratio
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Although we planned to perform an intention-to-treat
analysis, the GPs that were allocated to the intervention
group but did not follow the training, were lost to follow
up. The characteristics of these GPs differed slightly;
they were more likely to work fulltime and they had a
larger patient list. Being too busy probably caused their
absence. Next, only 57 % of the GPs returned the ques-
tionnaire with patient data, and therefore we could not
include their deceased patients in the analyses. Thirdly,
the positive effects we found regarding those patients
that had been identified as in need of palliative care,
were found in a post-hoc analysis, which has not been
described in the study protocol. These results need to be
explored further in future studies, as we don’t know
whether these differences are caused by the intervention
or because the identified patients are a selected group.
Lastly, it was not possible to prospectively register and
monitor patient data in the control group, and thus of
having quality of life as outcome measure.
Conclusions
This study shows that the design we chose was not com-
pletely compatible with an intervention that combined
identification of patients in need of palliative care and
anticipatory care planning. Only a portion of the eligible
patients had been identified, and in this subgroup a
post-hoc analysis showed positive effects of having iden-
tified patients as in need of palliative care and providing
anticipatory palliative care. For that reason, the absence
of differences between the entire intervention and con-
trol group does not show a failure of anticipatory pallia-
tive care; it reflects a low number of identified patients.
We have used the insights from this study to adapt
our methodology and to ensure that patients are
timely identified as in need of palliative care. These
adaptations are currently being applied in a prospect-
ive study on proactive supportive care in patients
with COPD. Patients are recruited by the attending
specialist at the moment of hospitalization for an
acute exacerbation COPD, palliative care is provided
by a dedicated hospital palliative care team, and the
primary outcome is quality of life [34].
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